Clinical Trial Details
| Trial ID: | L3953 |
| Source ID: | NCT02315495 |
| Associated Drug: | Saxagliptin |
| Title: | Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 Diabetes |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes |
| Interventions: | DRUG: Saxagliptin|DRUG: Acarbose |
| Outcome Measures: | Primary: Blood glucose concentrations at pre-defined intervals, -60,-10,0,30,60,90,120,180min | Secondary: Plasma concentrations of incretin hormones at pre-defined intervals, -60,-10,0,30,60,90,120,180min|Plasma concentrations of insulin at pre-defined intervals, -60,-10,0,30,60,90,120,180min|Plasma concentrations of C-peptide at pre-defined intervals, -60,-10,0,30,60,90,120,180min|Plasma concentrations of glucagon at pre-defined intervals, -60,-10,0,30,60,90,120,180min|half-emptying time (T50), 0-180min |
| Sponsor/Collaborators: | Sponsor: Zilin Sun |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 22 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2015-04-03 |
| Completion Date: | 2016-08-26 |
| Results First Posted: | |
| Last Update Posted: | 2018-07-06 |
| Locations: | Department of Endocrinology, Zhongda Hospital. Institute of Diabetes, Southeast University, Nanjing, Jiangsu, China |
| URL: | https://clinicaltrials.gov/show/NCT02315495 |
